This webinar will explore several of the therapeutic aimed clinical trials and efforts taking place in the world today for ALS. This includes Neuralstem, BrainStorm, TCA Cellular, Q-Therapeutics, California Stem Cell and Cedars-Sinai Medical Center. An overview of the landscape will be provided by Robert Goldstein of ALS TDI. Then, a detailed presentation will be provided by Dr. Yael Gothelf of BrainStorm Cell Therapeutics. A discussion between the panelists and those in the virtual audience will also take place. |